Liver disease (hepatitis, cirrhosis) Board decisions

The Board has remanded the case due to insufficient evidence regarding the cause of the Veteran's liver cancer and whether it is related to his service-connected PTSD.

The Board has remanded the case due to insufficient evidence regarding the Veteran's cause of death and his in-service herbicide exposure. The examiner is requested to provide an opinion on whether the Veteran’s cause of death was related to service.

The Board has remanded the Veteran's claims for cervical spine disorder, hepatitis C, and GERD due to potential exposure to contaminated water at Camp Lejeune. The VA is instructed to obtain updated VA treatment records, request SSA disability benefits records, and schedule the Veteran for a VA examination in each of these cases.

The Board has determined the Veteran's death is related to his active service, specifically his hepatitis C infection. However, additional evidence and medical opinions are needed to establish a clear link between these conditions and his military service.

The Veteran's death was not service-connected, and VA medical care did not contribute to his cause of death. The Board denied DIC benefits under 1318, 1151, and for the cause of death.

The Board denied service connection for hepatitis C and its residuals, finding no current diagnosis of the condition or evidence linking it to service.

The Veteran's medical expenses for treatment at St. Charles Medical Center from September 6 to September 8, 2012 are granted, subject to the payment limitations of 38 U.S.C. § 1725(c)(4).

The Veteran's claims for service connection are being remanded due to the need for additional development regarding potential herbicide exposure and private medical records.

The Veteran's hepatitis C was rated at 20 percent prior to February 17, 2007 and denied a higher rating. The Veteran also did not meet the criteria for SMC based on housebound status prior to this date.

The Board has granted service connection for hepatitis C and residuals of a kidney transplant, finding that the conditions are related to service.

The Veteran withdrew his appeal for hepatitis C during a video hearing, leading to the dismissal of this case.

The Board has remanded the claims for hepatitis C, rheumatoid arthritis, diabetes mellitus, numbness in the hands and feet, and a breathing and throat condition to obtain missing service treatment records.

The Veteran's claim for service connection for hepatitis C was denied in a February 2003 rating decision. The Board has determined that the issue remains pending and is remanded due to a substitution request.

The Veteran's hepatitis C is being remanded for further examination to determine if it is related to his service, including potential exposure during combat in Vietnam.

The Board has remanded the Veteran's claims for hepatitis C, lumbar spine condition, right knee condition, prostate cancer, and residuals of bladder cancer due to asbestos exposure. The issues are being returned to the AOJ for further review with consideration of new evidence.

The Veteran's claim for service connection for diabetes mellitus type II has been granted due to presumed exposure to herbicides. The compensable rating for his infectious hepatitis is remanded.

The Veteran's claims for service connection and initial ratings are being remanded due to the failure of VA to contact him at his new address in Georgia. The examinations scheduled for June 2018 have not been conducted, and a copy of the Supplemental Statement of the Case (SSOC) was sent to two prior addresses in South Carolina.

The Board has reopened the claim for service connection of hepatitis C and found that new evidence supports a reopening, but still denies the claim as there is no medical evidence linking current hepatitis C to service.

The Veteran's hepatitis C is granted as service connected. The lumbar spine disorder claim is remanded for further examination and evaluation. The TDIU claim is also remanded.

The Veteran's cause of death was due to advanced metastatic hepatocellular carcinoma, which is service-connected infectious hepatitis.